Posters
« Back
Development of Biomarkers for Improved Diagnosis of Active Tuberculosis
EP20057
Poster Title: Development of Biomarkers for Improved Diagnosis of Active Tuberculosis
Submitted on 19 Dec 2013
Author(s): Sybille Hunt, Amirkhani A, Cole R, Harcourt R,Hsu M , Marlborough D, Pedersen S, Qiu J, Ranaweera S, Remediakis C, Richards E, SeroaL, Sharp-Paul I, Sloane A, Vizgoft J, Harry J, Lindner R.
Affiliations: Proteome Systems Ltd
Poster Views: 727
View poster »


Poster Information
Abstract: The World Health Organisation (WHO) has declared the TB pandemic a global emergency with estimates that between 2000 and 2020, nearly one billion people will be newly infected, 200 million people will get sick, and 35 million will die from the disease. In the majority of the world, diagnosis of TB still relies on an insensitive 100-year-old technique of smear microscopy which ranges in sensitivity from 20-60% depending on the field and patient conditions. Development of a TB-antigen based test would result in improved diagnosis of TB.

Proteome Systems has taken a new approach to this problem by targeting human and TB proteins present in the body fluids of people infected with TB. Using novel proteomic technologies. Proteome Systems has identified TB proteins in sputa and blood of people diagnosed with TB. Several of these proteins have been prioritised for ongoing validation. This involves generation of sensitive antibodies and optimisation of assays for detection of TB antigens in clinical samples. This presentation will discuss our progress in this program and our strategy for incorporation of these markers into a diagnostic test format to facilitate improved diagnosis of this disease.
Summary: Proteome Systems has identified TB proteins in sputa and blood of people diagnosed with TB. Several of these proteins have been prioritised for ongoing validation. This involves generation of sensitive antibodies and optimisation of assays for detection of TB antigens in clinical samples.
Report abuse »
Creative Commons

Related Posters


BAT Molecular Imaging with SPECT-CT, PET-CT, PET-MRI and Fluorescence-PET: A Systematic Review of the Literature Data
Tarik Z Belhocine, MD., Ph.D *, Albert A Driedger, MD., Ph.D **, Jean-Luc Urbain, MD., Ph.D ***

PEAKS™ Software for the processing of timsTOF Pro PASEF data: identification and label-free quantitation
Markus Lubeck(1), Heiner Koch(1), Scarlet Beck(1), Paul Savage(2), Oliver Raether(1), Pierre-Olivier Schmit(2) Paul Shan (3) and Gary Kruppa (4)

Plasma proteomic profiling one year postpartum of women with Pre-eclampsia shows dysregulated cardiometabolic profile
Fatma S. Abad, Antigoni Manousopoulou, Diana J. Garay-Baquero, Brian R. Birch, Bas B. van Rijn, Spiros D. Garbis and Bashir A. Lwaleed

The Good, the Bad and the Ugly: Selective single cell isolation
Sandra Lubos1,2, Nils Körber1, Heide Marie Resch1, Iris Augustin2, Stefan Niehren1

Routine Analysis of Host Cell Proteins in Antibody Preparations using PASEF
Stuart Pengelley1, Guillaume Tremintin², Waltraud Evers1, Detlev Suckau1